A citation-based method for searching scientific literature

G Remberg, J Marsel, G Döring, G Spiteller. Arch Toxikol 1972
Times Cited: 16







List of co-cited articles
134 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


[Methamphetamine--a metabolite of the anorectics Benzphetamine and Furfenorex].
J Marsel, G Döring, G Remberg, G Spiteller. Z Rechtsmed 1972
23
43


The metabolic fate of 3H-fenetylline in man.
T Ellison, L Levy, J W Bolger, R Okun. Eur J Pharmacol 1970
29
37

Metabolism of DL-[14C]prenylamine in man.
G Remberg, M Eichelbaum, G Spiteller, H J Dengler. Biomed Mass Spectrom 1977
26
31



The metabolism of dimethylamphetamine in rat and man.
T Inoue, S Suzuki. Xenobiotica 1987
29
31



Time-lapse changes of d- and l-enantiomers of racemic (dl)-ethylamphetamine in human urine.
T Nagai, H Kanaya, K Matsushima, S Kamiyama. J Anal Toxicol 1997
9
55

The urinary output of d- and l-amphetamine in man.
L M Gunne. Biochem Pharmacol 1967
58
31

The metabolism of amphetamines in mammals.
J Caldwell. Drug Metab Rev 1976
97
31





Metabolism of mesocarb in the rat.
M Polgár, L Vereczkey, L Szporny, G Czira, J Tamás, E Gács-Baitz, S Holly. Xenobiotica 1979
14
28


Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
F Karoum, L W Chuang, T Eisler, D B Calne, M R Liebowitz, F M Quitkin, D F Klein, R J Wyatt. Neurology 1982
130
25







Determination of dl-fencamine in rat and human urine.
J Mallol, L Pitarch, R Coronas, A Pons. Arzneimittelforschung 1974
8
50


Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa.
M Schachter, C D Marsden, J D Parkes, P Jenner, B Testa. J Neurol Neurosurg Psychiatry 1980
89
25


Effects of urinary pH on amphetamine metabolism.
J M Davis, I J Kopin, L Lemberger, J Axelrod. Ann N Y Acad Sci 1971
59
18

Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration.
G P Reynolds, P Riederer, M Sandler, K Jellinger, D Seemann. J Neural Transm 1978
115
18

Urinary excretion kinetics of amphetamine in man.
A H Beckett, M Rowland. J Pharm Pharmacol 1965
191
18


Urinary excretion and metabolism of orally administered mefenorex.
S Rendić, M Slavica, M Medić-Sarić. Eur J Drug Metab Pharmacokinet 1994
5
60



The pharmacology of (-)deprenyl.
J Knoll. J Neural Transm Suppl 1986
48
18


Fenetylline: therapeutic use, misuse and/or abuse.
G Kristen, A Schaefer, A von Schlichtegroll. Drug Alcohol Depend 1986
22
18

Single- and multiple-dose pharmacokinetics of R-(-)-and S-(+)-prenylamine in man.
Y Gietl, H Spahn, H Knauf, E Mutschler. Eur J Clin Pharmacol 1990
11
27

Clinical use of appetite suppressants.
T Silverstone. Drug Alcohol Depend 1986
10
30



Appetite suppressants. A review.
T Silverstone. Drugs 1992
129
18


Identification of famprofazone ingestion.
F Musshoff, T Kraemer. Int J Legal Med 1998
8
37


Pharmacokinetics and metabolism of selegiline.
E H Heinonen, V Myllylä, K Sotaniemi, R Lamintausta, J S Salonen, M Anttila, M Savijärvi, M Kotila, U K Rinne. Acta Neurol Scand Suppl 1989
37
18

Detection and identification of famprofazone and its metabolite in human urine.
H S Shin, J S Park, P B Park, S J Yun. J Chromatogr B Biomed Appl 1994
13
23

Metabolic fate of fenetylline in rat and man.
H Yoshimura, T Yoshimitsu, H Yamada, N Koga, K Oguri. Xenobiotica 1988
10
30


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.